The cardiometabolic benefits of okra-based treatment in prediabetes and diabetes: a systematic review and meta-analysis of randomized controlled trials.
- 2024-12-12
- Systematic Review
- Frontiers in nutrition 11
- Hossein Bahari
- Mostafa Shahraki Jazinaki
- Iman Rahnama
- Ladan Aghakhani
- Mohammad Reza Amini
- Mahsa Malekahmadi
- PubMed: 39726865
- DOI: 10.3389/fnut.2024.1454286
- High evidence
- Clinical
fasting blood glucose (FBG) (WMD: -39.58 mg/dL; (95% CI: -61.60 to -17.56); p < 0.001)
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- ≤3,000 mg/day